Cadila Pharmaceuticals Ltd, Dr. Rajiv Modi,ÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.